Related references
Note: Only part of the references are listed.Mechanisms mediating the cardioprotective effects of rapamycin in ischaemia-reperfusion injury
You-Bin Liu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633
Zhen Chen et al.
CIRCULATION RESEARCH (2009)
Diabetes, Oxidative Stress, Nitric Oxide and Mitochondria Function
Malou Friederich et al.
CURRENT DIABETES REVIEWS (2009)
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts
Gabriella F. Kocsis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice
Omar Bouhidel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Long-term benefit of postconditioning
Helene Thibault et al.
CIRCULATION (2008)
Cardioprotection by Postconditioning Is Lost in WOKW Rats With Metabolic Syndrome: Robe of Glycogen Synthase Kanase 3P
Claudia Wagner et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
The paradigm of postconditioning to protect the heart
C. Penna et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Remote renal preconditioning-induced cardioprotection: a key role of hypoxia inducible factor-prolyl 4-hydroxylases
Ravi Kant et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Mechanisms of disease: Myocardial reperfusion injury
Derek M. Yellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat
Suresh Varma Penumathsa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Akt in ischemia and reperfusion
Carolyn J. Mullonkal et al.
JOURNAL OF INVESTIGATIVE SURGERY (2007)
Statins activate AMP-activated protein kinase in vitro and in vivo
Wei Sun et al.
CIRCULATION (2006)
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2
S Atar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts
P Di Napoli et al.
CARDIOVASCULAR RESEARCH (2005)
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment - A potential role for phosphatase and tensin homolog deleted on chromosome ten?
K Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
AMP-Activated protein kinase: A key stress signaling pathway in the heart
LH Young et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: Mechanisms and management
RT Hurst et al.
ANNALS OF INTERNAL MEDICINE (2003)
Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway
RM Bell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)